SPOTLIGHT -
Fecal Microbiota Transplant Outcomes and Therapy Advances
Read More
Fecal Microbiota Transplant for Recurrent vs Refractory CDI
IDSA/SHEA Guidelines Update and ID Week: Bezlotoxumab
Expanded Role of Fidaxomicin in Treatment of CDI
Treatment Recommendations from IDSA/SHEA for CDI
Risk Factors for Recurrence of Clostridioides Difficile
Frequency of CDI Recurrence and Impact on Quality of Life
Clostridioides Difficile: Exciting Developments
Antibiotic Microbial Resistance & RBX7455 for C Diff
RBX2660 for Recurrent Clostridioides Difficile
Managing Recurrent Clostridium Difficile Infections
Clostridioides Difficile Pathogenesis & Manifestation
Community Outreach for Dental Antibiotic Stewardship
Debra Goff, PharmD, describes the success of a community outreach approach to spreading the word about antimicrobial stewardship among dentists and orthopedic surgeons.
HIV Clinic Improvement and Community Engagement
Gregory Felzien, MD, discusses the surprising benefits HIV clinics encounter when they enhance community engagement.
Recalls That Should Be On Your Radar—Week of June 17, 2018
In case you missed them, we’ve compiled a list of the latest recalls posted this week.
Latest Results of the Population-Based HIV Impact Assessment Project
Jessica Justman, MD, reveals the latest results of the Population-based HIV Impact Assessment Project (2017).
